Form 8-K - Current report:
SEC Accession No. 0001193125-22-157444
Filing Date
2022-05-23
Accepted
2022-05-23 16:06:06
Documents
12
Period of Report
2022-05-17
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d283470d8k.htm   iXBRL 8-K 27547
  Complete submission text file 0001193125-22-157444.txt   146795

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20220517.xsd EX-101.SCH 2873
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20220517_lab.xml EX-101.LAB 17237
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20220517_pre.xml EX-101.PRE 10824
6 EXTRACTED XBRL INSTANCE DOCUMENT d283470d8k_htm.xml XML 3261
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 22951599
SIC: 2834 Pharmaceutical Preparations